In men, a prolactinoma often presents with subtle, progressive symptoms that can be easily overlooked or attributed to the natural aging process. As a benign tumour of the pituitary gland, a prolactinoma causes the autonomous overproduction of prolactin, a hormone that, in high levels, significantly disrupts the male reproductive and endocrine systems. Because the pituitary gland is the master regulator of the body’s hormones, an excess of prolactin creates a secondary suppression of the hypothalamic-pituitary-gonadal axis, primarily leading to a deficiency in testosterone. In the United Kingdom, men are frequently diagnosed at a later stage than women because the symptoms, such as a gradual loss of libido, are less dramatic than a sudden cessation of a menstrual cycle. Recognizing these clinical markers early is essential to prevent long-term complications such as vision loss or significant bone density reduction.
What We’ll Discuss in This Article
- The primary impact of high prolactin on male libido and sexual function.
- Physical changes associated with testosterone suppression and breast tissue.
- Systemic signs of pituitary dysfunction and hormone deficiencies.
- Neurological symptoms caused by the physical size of the tumour.
- The long term metabolic and skeletal risks for men with untreated prolactinomas.
- The clinical significance of “mass effect” in male patients.
- Answers to frequently asked questions regarding male-specific symptoms.
Impact on libido and sexual function
The most frequent and characteristic symptom of a prolactinoma in men is a significant and persistent reduction in libido or sex drive. High levels of prolactin act directly on the brain and the pituitary gland to suppress the production of luteinising hormone and follicle stimulating hormone. These are the chemical messengers that tell the testes to produce testosterone. As testosterone levels fall, men often experience a gradual loss of interest in sexual activity, which is frequently the first clinical sign of the disorder.
In addition to a low libido, men may suffer from erectile dysfunction or a reduction in the quality and frequency of morning erections. According to the Society for Endocrinology, sexual dysfunction is present in approximately 80 to 90 percent of men diagnosed with a prolactinoma. Because these symptoms can be caused by various factors such as stress or cardiovascular issues, they are often dismissed for years. However, when these symptoms are combined with a persistent lack of energy, they should be investigated as a potential endocrine issue.
Systemic signs of pituitary dysfunction
If a prolactinoma grows large enough to become a macroadenoma, it can physically compress the surrounding healthy parts of the pituitary gland, leading to broader pituitary dysfunction. This compression can cause a deficiency in other vital hormones, such as Thyroid Stimulating Hormone or Adrenocorticotropic Hormone. When this happens, a man may develop systemic symptoms of an underactive thyroid or adrenal insufficiency, which manifest as extreme fatigue, weight gain, and a general feeling of being unwell.
Fatigue is a particularly debilitating symptom for men with prolactinomas. It is often described as an overwhelming lethargy that does not improve with rest and can significantly impact a person’s ability to work or exercise. According to the Pituitary Foundation, this “all encompassing” tiredness is often what finally drives a man to seek medical help after years of ignoring more subtle sexual symptoms. Monitoring the entire pituitary profile is essential for UK specialists to ensure that all hormone deficiencies are identified and replaced if necessary.
Neurological symptoms and mass effect
Because men are often diagnosed later than women, they are more likely to present with tumours that have grown large enough to cause neurological symptoms. These are known as mass effects and occur when the tumour presses against the surrounding brain structures. The most common mass effect is a persistent, dull headache that is often located behind the eyes or in the temple area. These headaches are caused by the expansion of the tumour within the sella turcica, the bony compartment that houses the pituitary gland.
A far more serious symptom of a large prolactinoma is visual field loss. The pituitary gland sits directly beneath the optic chiasm, where the nerves from the eyes cross. A macroadenoma can press upwards against these nerves, causing a loss of peripheral vision, often referred to as bitemporal hemianopsia. Many men do not notice this until it is quite severe, as the brain tends to compensate for the missing parts of the visual field. The NHS guidance on pituitary tumours emphasizes that any changes in vision or persistent new headaches require urgent investigation to prevent permanent neurological damage.
Long term skeletal and metabolic risks
Untreated prolactinoma and the resulting chronic low testosterone carry significant long-term risks for male health, particularly regarding bone density. Testosterone is essential for maintaining bone strength in men, and its deficiency leads to a higher risk of osteoporosis and bone fractures. This is an “invisible” symptom that only becomes apparent through a DEXA scan or an unexpected fracture. In the UK, specialists often recommend bone density monitoring for men who have had low testosterone for more than a year.
Metabolic changes are also common in men with high prolactin. Low testosterone levels are associated with insulin resistance and an increased risk of developing type 2 diabetes and cardiovascular disease. Research published in the British Medical Journal suggests that restoring the hormonal balance not only improves sexual function but also significantly enhances metabolic markers and reduces long term health risks. Management focus in the UK is increasingly moving towards this holistic view of patient health, ensuring that the cardiovascular and skeletal systems are protected alongside the treatment of the tumour.
Conclusion
In men, the symptoms of a prolactinoma are often subtle and revolve around a slow loss of libido, erectile dysfunction, and systemic fatigue. Because these signs are non-specific, they are frequently ignored, leading to a higher rate of large tumours that cause headaches and vision loss. Early recognition of these hormonal and neurological clusters is vital to restore testosterone levels, protect bone health, and prevent permanent damage to the eyes. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can a prolactinoma cause male infertility?
Yes, high prolactin suppresses the hormones needed for sperm production, leading to a low sperm count and reduced fertility.
Will my sex drive return after the tumour is treated?
In most cases, yes; once prolactin levels are lowered and testosterone is restored, libido and sexual function usually improve significantly.
Why does a pituitary tumour cause headaches?
Headaches occur when the growing tumour stretches the sensitive tissues surrounding the gland or increases pressure within the skull.
Can I have a prolactinoma without any breast changes?
Yes, gynaecomastia and galactorrhoea are actually less common in men than the primary symptoms of low libido and fatigue.
Is weight gain common in men with this condition?
Yes, low testosterone can cause a change in body composition, leading to increased fat storage and difficulty maintaining muscle mass.
How is a prolactinoma in men usually treated in the UK?
The first line of treatment is almost always medication (dopamine agonists) which is very effective at shrinking the tumour and restoring hormone levels.
Can high prolactin affect my mood?
Yes, many men report increased irritability, anxiety, or symptoms of depression, which are often linked to the chronic lack of testosterone.
Authority Snapshot
This article provides a clinical overview of the symptoms suggesting a prolactinoma in men to support patient education in the United Kingdom. The content has been authored by a specialized medical content team and reviewed by Dr. Rebecca Fernandez to ensure the highest standards of clinical accuracy. All information presented is strictly aligned with the latest NHS guidelines and UK endocrine society standards to provide reliable and safe information for patients.
